Publications by authors named "Beli Gao"
Int Immunopharmacol
December 2024
Article Synopsis
- The study investigates immune checkpoint inhibitor-associated pneumonitis (CIP) in non-small cell lung cancer (NSCLC) patients receiving anti-PD-1 therapy, aiming to identify risk factors and their impact on prognosis.
- Out of 229 patients analyzed, 15.3% experienced CIP, with higher occurrences among males and those with prior smoking or lung disease; elevated CD4 T lymphocytes and AEC were found to be significant predictors of CIP.
- The presence of CIP was linked to improved progression-free survival and better treatment efficacy, highlighting the necessity for early detection and intervention.
